English | Español
Robert Hadley | Jun 25, 2017

NIH study to examine impact of Zika virus on young children in Guatemala
Robert Hadley | Jun 25, 2017

Potential leukemia drug better aimed at muscular dystrophy, NIH says
Ruth de Jauregui | Jun 23, 2017

Study of antiplatelet drug based on snake venom shows promising results
Robert Hadley | Jun 23, 2017

Pfizer clinical trial seeks Group B Streptococcus vaccine 
Nicholas Gueguen | Jun 23, 2017

AbbVie says Imbruvica more effective than chlorambucil in fighting chronic lymphocytic leukemia
Robert Hadley | Jun 23, 2017

Study explores eye contact avoidance by those with autism

Erianne Leatherman | Jun 22, 2017

Chemotherapy can affect breast cancer patients’ gait and balance
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’